Noze

🚀 Breaking News! 🚀 We’re thrilled to announce that Noze has secured a $5M equity investment from the Bill & Melinda Gates Foundation, anchoring our latest funding round! This investment further fuels our mission to revolutionize healthcare through breath-based diagnostics. With exceptional partners like BMGF, we're not just dreaming big; we're making it happen. But wait, there’s more—this also marks their first-ever investment in Canada 🇨🇦! What a privilege for Team Noze! Check out the press release to learn more 👉 https://lnkd.in/ep-syykm #Innovation #Healthcare #TechForGood #StartupLife #Funding #DiseaseDetection #Breathomics #Breathalyzer #Healthtech BDC Mistral Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économiq Global Affairs Canada | Affaires mondiales Canada Health Canada | Santé Canada

🏆 Meet our Noze-Worthy Achiever for July! We're stoked to shout out Josh Campbell this month for absolutely crushing it! Josh joined us in January as a Product Development Co-op Student and has embraced the startup hustle with gusto. Over the past seven months, his hustle, dedication, and top-notch performance have truly made him a stand out around here. We’re proud to have you on the Noze team as we keep making magic happen Josh! 🎧 Fun Fact: Josh's go-to jam for getting in the zone is ‘Heavy Eyes’ by Zach Bryan.

We're thrilled to share the grand opening of our new global headquarters, right here in Ville de Montréal 🇨🇦 This isn’t just an office; it’s a symbol of our journey, a celebration of our success, and a shining example of what local startups can achieve with hustle, tenacity, and the support of great partners. Here’s to the power of dreaming big and making it happen! #StartupLife #Entrepreneurship #DreamBig Mistral BDC Bill & Melinda Gates Foundation National Research Council Canada / Conseil national de recherches Canada Dentons Institut Cardiologie de Montréal Centre universitaire de santé McGill | McGill University Health Centre CHUM - Centre hospitalier de l'Université de Montréal Finalta Capital Roynat Capital BMO Capital Markets RBCx

👃 Check out our CEO Karim Aly's latest interview in Technology Networks, 'Sniffing Out Disease With “Scentprints”', where he discusses the application and potential of digital odor perception in the field of disease detection & diagnostics. ➡ You can read the full interview here: https://lnkd.in/eGh_3tK7

Exciting news! We’re thrilled to announce a new grant from the Bill & Melinda Gates Foundation to fund a groundbreaking clinical study aimed at detecting tuberculosis in high-burden countries. The study will use our handheld diagnostic breathalyzer and is expected to begin in the Fall of 2024. Check out the press release to learn more about this exciting partnership 👉 https://lnkd.in/ecdcUqT5 #BMGF #Tuberculosis #EarlyScreening #DiseaseDetection #Breathalyzer #Healthtech #Noze

🚀 Event announcement! We’re excited to announce our inaugural event in partnership with Creative Destruction Lab (CDL-Montreal): DiagNoze ‘24 - a one-of-a-kind symposium delving into the future of healthcare, on April 19, 2024. This year’s theme is “How breath will unlock the next era of breath diagnostics”. 🌟 Our symposium is bringing together a curated group of pioneers, visionaries, and innovators, all dedicated to reshaping the world. We’re thrilled to announce our speaker lineup, including Margie L. Homer, Dr. Sarkis Meterissian, Thomas Van Gilder, MD, JD, MPH, Paul Thomas and Noze's own Ashok Prabhu Masilamani! 📩 To request an invite, email [email protected]!

💥 Check out our CEO Karim Aly's latest article "Breath-based Analysis: Revolutionizing Disease Screening for a Healthier Tomorrow" in MedTech Intelligence where he talks about the potential of breath-based screening for potentially life-threatening illnesses like lung cancer, breast cancer and tuberculosis. 👉 Read the full article here: https://lnkd.in/gj_mpwqf #EarlyScreening #DiseaseDetection #Breathalyzer #Healthtech #Noze

👉 Check out our latest article on “The Future Of Early Disease Detection: Breath-based Screening & Diagnostics” featured in Med Device Online. See how our AI-powered digital olfaction platform can offer a rapid, non-invasive way to detect diseases early, overcoming traditional diagnostic challenges like patient discomfort, delayed diagnoses, and high costs. Stay tuned for more updates about our handheld diagnostic breathalyzer as we usher in a new era of breath-based screening and diagnostic devices! 🙌 🔗 Read the full article here: https://lnkd.in/giEVatGT #EarlyDiagnosis #Innovation #Healthcare #Noze

🎓 Exciting updates for CDL-Montreal graduates in 2024!  👉🏼 Local Logic partnered with Nestfully, integrating advanced insights for an enhanced homebuying experience.  👉🏼 Noze's CEO, Karim Aly, shared plans for digital odor tech in diagnostics and 2024 objectives, including securing Series B funding.  👉🏼  Waste Robotics advances with a planned expansion, strategically aligned to support their commitment to innovation and sustained growth. 🚀 Stay tuned for more info on our graduates. #BuildSomethingMassive #AI #SupplyChain #Web3 #CDLMontrealGraduateNews /// 🎓 Mises à jour passionnantes pour les diplômés du CDL-Montréal en 2024 ! 👉🏼 Local Logic s'est associé à Nestfully, intégrant des informations avancées pour une expérience d'achat immobilier améliorée. 👉🏼 Le PDG de Noze, Karim Aly, a partagé ses projets en matière de technologie numérique des odeurs pour les diagnostics et ses objectifs pour 2024, notamment l'obtention d'un financement de série B. 👉🏼 Waste Robotics va de l'avant avec une expansion planifiée, stratégiquement alignée pour soutenir son engagement en faveur de l'innovation et d'une croissance soutenue. 🚀 Restez à l'affut des nouvelles sur nos diplômés! #VoyezGrandOsezGrand #IA #ChaîneApprovisionnement #Web3 #NouvellesDiplômésCDLMontreal

📣 We're thrilled to announce the recruitment of the first participant in our breast cancer screening study in partnership with Dr. Sarkis Meterissian. Dr. Meterissian, a practicing physician and distinguished Professor of Surgery and Oncology, serves as an Associate Investigator in the Cancer Research Program at the Centre universitaire de santé McGill | McGill University Health Centre and is President of the Medical Advisory Board of the Quebec Breast Cancer Foundation. His research focuses on the diagnosis, pathogenesis, and prognosis of breast cancer. Our collaboration with Dr. Meterissian targets the development of a rapid, non-invasive and cost-effective breast cancer screening tool that works by analyzing an individual's breath 💨 Stay tuned for more updates as we journey towards redefining the future of cancer screening! 🙌 #EarlyDiseaseDetection #DigitalOlfaction #BreastCancer #Innovation #BreathBasedScreening #Healthcare